Metraipolis › archive › dc_3cd8fe84a129

Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics — Europe PMC PMID:42148062

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42148062
DOI: 10.3389/fimmu.2026.1819131
License (as archived): solo-consultazione
Archived: 2026-11-03T01:18:37.744Z
SHA-256 of the archived text: 5c130e3283eb1fee24990d2aadbb0c758cdfc57788793874b368d3a99ec7e3cb
Stable URL of this page: https://metraipolis.com/documento/dc_3cd8fe84a129

How to cite

Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics — Europe PMC PMID:42148062 — Europe PMC (en), https://europepmc.org/article/MED/42148062 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cd8fe84a129 (Metraipolis archive dc_3cd8fe84a129, sha256 5c130e3283eb1fee24990d2aadbb0c758cdfc57788793874b368d3a99ec7e3cb)

BibTeX

@misc{dc3cd8fe84a129,
  title = {Unraveling immunological heterogeneity in recalcitrant AIH-PBC/PSC overlap syndromes: from molecular crosstalk to precision therapeutics — Europe PMC PMID:42148062},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42148062},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cd8fe84a129; sha256 5c130e3283eb1fee24990d2aadbb0c758cdfc57788793874b368d3a99ec7e3cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148062. Agents can read the archived copy with the MCP tool read_document.